Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2016) | Total Docs. (3years) | Total Refs. (2016) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2016) | %Female (2016) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Perspectives in Medicinal Chemistry | journal | 2.425 Q1 | 17 | 2 | 8 | 277 | 83 | 8 | 10.38 | 138.50 | 40.00 |  |
| 2 | Diabetes, Metabolic Syndrome and Obesity | journal | 1.586 Q1 | 64 | 45 | 168 | 2511 | 744 | 165 | 4.42 | 55.80 | 38.10 | |
| 3 | Infection and Drug Resistance | journal | 1.551 Q1 | 65 | 33 | 101 | 1683 | 449 | 101 | 4.89 | 51.00 | 36.27 | |
| 4 | Pharmacogenomics and Personalized Medicine | journal | 1.208 Q1 | 37 | 15 | 67 | 912 | 289 | 67 | 4.76 | 60.80 | 40.48 | |
| 5 | International Journal of Nanomedicine | journal | 1.174 Q1 | 179 | 487 | 1501 | 23728 | 7347 | 1472 | 4.56 | 48.72 | 43.58 | |
| 6 | Nanotechnology, Science and Applications | journal | 1.048 Q1 | 35 | 4 | 12 | 548 | 106 | 12 | 8.83 | 137.00 | 27.78 | |
| 7 | Drug Design, Development and Therapy | journal | 0.993 Q1 | 94 | 363 | 908 | 15594 | 2911 | 893 | 3.04 | 42.96 | 37.71 | |
| 8 | Core Evidence (discontinued) | journal | 0.965 Q2 | 29 | 5 | 28 | 371 | 116 | 27 | 4.24 | 74.20 | 43.75 | |
| 9 | Patient Preference and Adherence | journal | 0.790 Q1 | 67 | 254 | 477 | 9951 | 1091 | 466 | 2.04 | 39.18 | 48.33 | |
| 10 | Therapeutics and Clinical Risk Management | journal | 0.765 Q1 | 70 | 211 | 378 | 8586 | 940 | 365 | 2.55 | 40.69 | 34.84 | |
| 11 | Biomarker Insights | journal | 0.699 Q2 | 40 | 29 | 97 | 1744 | 195 | 95 | 1.79 | 60.14 | 44.79 | |
| 12 | Drug, Healthcare and Patient Safety | journal | 0.531 Q3 | 30 | 13 | 66 | 469 | 112 | 60 | 1.95 | 36.08 | 40.48 | |
| 13 | Fluoride - Quarterly Reports | journal | 0.332 Q4 | 51 | 55 | 108 | 1702 | 184 | 98 | 1.84 | 30.95 | 40.80 | |
| 14 | Open Access Journal of Clinical Trials | journal | 0.305 Q2 | 15 | 6 | 27 | 162 | 24 | 25 | 0.54 | 27.00 | 27.27 | |
| 15 | Clinical Medicine Insights: Therapeutics | journal | 0.212 Q3 | 11 | 9 | 25 | 551 | 11 | 25 | 0.25 | 61.22 | 22.22 | |
| 16 | Journal of Receptor, Ligand and Channel Research | journal | 0.196 Q4 | 13 | 1 | 16 | 137 | 7 | 16 | 0.50 | 137.00 | 25.00 | |
| 17 | Journal of Experimental Pharmacology | journal | 0.162 Q4 | 23 | 8 | 6 | 369 | 8 | 6 | 0.80 | 46.13 | 26.92 | |
| 18 | Orphan Drugs: Research and Reviews | journal | 0.126 Q4 | 4 | 0 | 12 | 0 | 2 | 12 | 0.17 | 0.00 | 0.00 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data